Results 231 to 240 of about 766,404 (301)

Role of Genetic and Epigenetic Biomarkers in Treatment-Resistant Depression: A Literature Review. [PDF]

Genes (Basel)
Sulić P, Ražić Pavičić A, Đapić Ivančić B, Božina T, Božina N, Živković M.   +5 more
europepmc   +1 more source

Impaired regional structure-function coupling as novel neurophenotype: mechanistic insights and diagnostic exploration in treatment-resistant depression. [PDF]

Npj Ment Health Res
Ye X, Ye S, Wei S, Chen X, Zhou Z, Zhao H, Zhang S, Li Y, Xu P, Wu R, Shang D, Lin B, Si K, Qi X, Li G, Pan F, Chen J, Hu J, Yin J, Cui D, Huang M.   +20 more
europepmc   +1 more source

Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response. [PDF]

BMC Psychiatry
Baune BT, Rosemann K, Hefter D, Tonkul M, Kavakbasi E.   +4 more
europepmc   +1 more source

Spectroscopic and In Silico Determination of the Structural and Antioxidant Properties of Essential Oils From Lavandula Species Cultivated in the Silivri Region of Istanbul

Journal of the American Oil Chemists' Society, EarlyView.
ABSTRACT Plants are important sources of bioactive compounds that contribute to nutrition, health maintenance, and disease prevention. In this study, the chemical composition and antioxidant potential of essential oils obtained from Lavandula angustifolia “Sevtopolis” and Lavandula × intermedia cultivated in the Silivri region of Istanbul were ...
Bilge Bicak, Beray Kizilkaya, Serda Kecel Gunduz, Aliye Demet Demirag, Sabriye Percin Ozkorucuklu   +4 more
wiley   +1 more source

Heart Rate Metrics as Potential Biomarkers for Predicting Transcranial Magnetic Stimulation Treatment Response in Treatment-Resistant Depression

Chang H, Chang C, Lai T, Chang H, Liu Y, Sack A.   +5 more
europepmc   +1 more source

Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression. [PDF]

Ther Adv Psychopharmacol
Patarroyo-Rodriguez L, Pazdernik VK, Vande Voort JL, Kung S, Singh B.   +4 more
europepmc   +1 more source

Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study. [PDF]

Ther Adv Psychopharmacol
Cuomo A, McIntyre R, Koukouna D, Pinzi M, Pardossi S, Firenzuoli B, Barillà G, Carmellini P, Alamia A, Fagiolini A.   +9 more
europepmc   +1 more source

Association Between Plasma SITH-1 Antibody Titers and Treatment Trajectory of Treatment-Resistant Depression. [PDF]

Neuropsychopharmacol Rep
Mori K, Kodaka F, Ishii J, Oka N, Kondo K, Kito S.   +5 more
europepmc   +1 more source

Toward Integrating Intranasal Esketamine with Traumatic-Memory Psychotherapy in Treatment-Resistant Depression: A Narrative Review and Feasibility-Oriented Protocol Proposal. [PDF]

Behav Sci (Basel)
Raffone F, Cattaneo CI, Pessina E, Martini A, Martiadis V.   +4 more
europepmc   +1 more source